UPDATE: Stifel Starts Relay Therapeutics (RLAY) at Buy, PT $40
Tweet Send to a Friend
(Updated - September 1, 2022 4:09 PM EDT)
Stifel analyst Bradley Canino initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Bradley Canino initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
